Notably, IHC analysis for cleaved Caspase-3 revealed that CBL0137 combined with anti-NKG2A significantly increased the percentage of apoptotic tumor cells compared to single agent treatments (Fig. 7D, E). This evidence concerns the gene CASP3 and neoplasm.